These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36549916)

  • 1. Distinguishing Progression from Pseudoprogression in Glioblastoma Using
    Nabavizadeh A; Bagley SJ; Doot RK; Ware JB; Young AJ; Ghodasara S; Zhao C; Anderson H; Schubert E; Carpenter EL; Till J; Henderson F; Pantel AR; Chen HI; Lee JYK; Amankulor NM; O'Rourke DM; Desai A; Nasrallah MP; Brem S
    J Nucl Med; 2023 Jun; 64(6):852-858. PubMed ID: 36549916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Henderson F; Brem S; O'Rourke DM; Nasrallah M; Buch VP; Young AJ; Doot RK; Pantel A; Desai A; Bagley SJ; Nabavizadeh SA
    Neurooncol Pract; 2020 Mar; 7(2):152-157. PubMed ID: 32206320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study.
    Brahm CG; den Hollander MW; Enting RH; de Groot JC; Solouki AM; den Dunnen WFA; Heesters MAAM; Wagemakers M; Verheul HMW; de Vries EGE; Pruim J; Walenkamp AME
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2404-2412. PubMed ID: 30032322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas.
    de Godoy LL; Mohan S; Wang S; Nasrallah MP; Sakai Y; O'Rourke DM; Bagley S; Desai A; Loevner LA; Poptani H; Chawla S
    J Transl Med; 2023 Apr; 21(1):287. PubMed ID: 37118754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET.
    Werner JM; Weller J; Ceccon G; Schaub C; Tscherpel C; Lohmann P; Bauer EK; Schäfer N; Stoffels G; Baues C; Celik E; Marnitz S; Kabbasch C; Gielen GH; Fink GR; Langen KJ; Herrlinger U; Galldiks N
    Clin Cancer Res; 2021 Jul; 27(13):3704-3713. PubMed ID: 33947699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory Analysis of Serial
    Fatania K; Frood R; Tyyger M; McDermott G; Fernandez S; Shaw GC; Boissinot M; Salvatore D; Ottobrini L; Teh I; Wright J; Bailey MA; Koch-Paszkowski J; Schneider JE; Buckley DL; Murray L; Scarsbrook A; Short SC; Currie S
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884545
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F
    Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequential implementation of DSC-MR perfusion and dynamic [
    Steidl E; Langen KJ; Hmeidan SA; Polomac N; Filss CP; Galldiks N; Lohmann P; Keil F; Filipski K; Mottaghy FM; Shah NJ; Steinbach JP; Hattingen E; Maurer GD
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1956-1965. PubMed ID: 33241456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the extent of tumor resection at surgical planning with
    Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M
    Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
    Tade FI; Cohen MA; Styblo TM; Odewole OA; Holbrook AI; Newell MS; Savir-Baruch B; Li X; Goodman MM; Nye JA; Schuster DM
    J Nucl Med; 2016 Sep; 57(9):1357-63. PubMed ID: 27056619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma.
    Bogsrud TV; Londalen A; Brandal P; Leske H; Panagopoulos I; Borghammer P; Bach-Gansmo T
    Clin Nucl Med; 2019 Aug; 44(8):605-611. PubMed ID: 31274605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Glioblastoma With
    Scarpelli ML; Healey DR; Mehta S; Quarles CC
    Front Oncol; 2022; 12():829050. PubMed ID: 35174096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma PET/MRI: kinetic investigation of [
    Lindemann M; Oteiza A; Martin-Armas M; Guttormsen Y; Moldes-Anaya A; Berzaghi R; Bogsrud TV; Bach-Gansmo T; Sundset R; Kranz M
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1183-1194. PubMed ID: 36416908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI.
    Wang S; Martinez-Lage M; Sakai Y; Chawla S; Kim SG; Alonso-Basanta M; Lustig RA; Brem S; Mohan S; Wolf RL; Desai A; Poptani H
    AJNR Am J Neuroradiol; 2016 Jan; 37(1):28-36. PubMed ID: 26450533
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Selnæs KM; Krüger-Stokke B; Elschot M; Willoch F; Størkersen Ø; Sandsmark E; Moestue SA; Tessem MB; Halvorsen D; Kjøbli E; Angelsen A; Langørgen S; Bertilsson H; Bathen TF
    Eur Radiol; 2018 Aug; 28(8):3151-3159. PubMed ID: 29294158
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Tom MC; DiFilippo FP; Jones SE; Suh JH; Obuchowski NA; Smile TD; Murphy ES; Yu JS; Barnett GH; Angelov L; Mohammadi AM; Huang SS; Wu G; Johnson S; Peereboom DM; Stevens GHJ; Ahluwalia MS; Chao ST
    J Neurooncol; 2023 Jul; 163(3):647-655. PubMed ID: 37341842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.